2024 asm

Upcoming ASM

2024 HBPRCA Annual Scientific Meeting

Date : 27 - 29 November 2024
Location : Sydney

The Hypertension Australia Annual Scientific Meeting is the premier conference on hypertension research in Australia.

The ASM supports members and students presenting their latest research findings. The meeting comprises special sessions and prizes for students and young investigators, as well as the Judith Whitworth Women in High Blood Pressure Award, the Jaye Chin-Dusting Mid-career Scientist in High Blood Pressure Research Award and the Paul Korner Senior Scientist in High Blood Pressure Research Medal. The meeting highlights include 3 named lectures: The RD Wright, the Austin E Doyle and the Colin I Johnston lectureships awarded to leading scientists or physicians.

ASM 2024

Key Dates

Abstract Submission : NOW OPEN
Abstract Submission CLOSE: 1 OCTOBER 2023

Registrations : NOW OPEN
Early Bird closes 1 October 2023

Guest Speakers

RD Wright Lecturer: Professor Richard McManus

Professor of Primary Care Research, Nuffield Department of Primary Care Health Sciences, Oxford University, UK.

Richard McManus held four consecutive NHS/NIHR National Research Fellowships (DRF-Professorship, 2001-18) and was awarded an NIHR Senior Investigator Award in 2019. His main research interests are in the prevention of cardiovascular disease including following hypertensive pregnancy, in the context of multiple long-term conditions and when deprescribing may be appropriate. He is Chief Investigator on an NIHR Programme Grant around Postnatal Self-Management of Blood Pressure following Pregnancy Hypertension and leads the self-management theme of the Oxford Thames Valley ARC. He is joint Chief Investigator of the OPTIMISE2 study assessing deprescribing antihypertensives in the over 75s. He is recognised internationally for his work on self-monitoring and self-management of hypertension and leads a consortium curating 25 datasets which form an individual patient data meta-analysis of self-monitoring of hypertension. He chairs the Blood Pressure Monitoring Working Party of the British Hypertension Society and has provided expert advice to NICE (2011 & 2019 Hypertension Guideline) and the European Society of Cardiology/European Society of Hypertension (2018 & 2024 European Hypertension Guidelines). He leads Oxford’s input into the School for Primary Care Research and chairs the NIHR Research Professors Selection Panel. He is chair of the PROMPPT programme steering committee and is a member of the NIHR Programme Grants for Applied Health Research Panel.

Colin I Johnston Lecturer: A/Professor Jun Yang

Hudson Institute of Medical Research, Clayton VIC.

Associate Professor Jun Yang (MBBS, PhD, FRACP) is a clinician-researcher who heads the Endocrine Hypertension Group at Hudson Institute of Medical Research. She is also a Research Fellow in the School of Clinical Sciences at Monash University and a Consultant Endocrinologist at Monash Health. Since graduating with a MBBS (Hons, rank number 1) from Monash University, she has been actively involved in basic and clinical research as well as clinical practice. She undertook PhD studies with Dr Morag Young, Dr Colin Clyne and Professor Peter Fuller at Prince Henry’s Institute of Medical Research, now Hudson Institute, from 2008-2013. Her PhD thesis, entitled ‘Mineralocorticoid receptors (MR): mechanisms of ligand- and tissue-specific activation’, identified and characterised novel coregulators of the MR using a novel phage display technique in addition to cell culture work and gene expression assays. In addition to laboratory-based research, A/Prof Yang established the Endocrine Hypertension Service at Monash Health and Hudson Institute with Professor Peter Fuller. She developed the Monash Health guidelines for the management of primary aldosteronism (PA) in 2010 and has since expanded the PA research program including collaborations with centres in America as a part of the American-Asian-Australian-Adrenal- Alliance (A5), Europe (Germany, Italy, Netherlands) and Asia (China, Taiwan). In December 2018, A/Prof Yang formed the Primary Aldosteronism Centre of Excellence (PACE) to consolidate the capabilities of a team of dedicated hypertension researchers within Australia to drive impactful change in the clinical management of PA.

Austin Doyle Lecturer: A/Professor Nikola Bowden

University of Newcastle, Newcastle NSW.

Awarding-winning molecular biologist Associate Professor Nikola Bowden is giving existing cancer drugs new life by combining them in unconventional ways with exciting results. Over the years, the process of finding new cancer drug treatments has followed a strict pathway: the research reveals a biological discovery, which leads to a new drug discovery, drug development and testing through multiple stages of clinical trials. The problem is, this entire process can take 15-20 years to complete. Which means that a patient who is diagnosed with aggressive cancer today will be unlikely to benefit from the most recent biological discoveries and subsequent treatments. “We need to rethink our conventional approach to cancer research,” asserts Associate Professor Nikola Bowden, whose research focuses on repurposing existing cancer drugs. “We are wasting years of research and knowledge by shelving old drugs and trying to always find new ones.” Instead of focusing on creating new drugs, Nikola and her team are looking at how existing drugs can be used in new ways. For cancer patients who need more immediate solutions, her work is having a meaningful impact. “Using current drugs in new ways is called drug repurposing. We know so much about safety, dosing and side effects of the drugs we already use, it is ideal to also see if they have anti-cancer activity. We need to start using the drugs we already have to their full potential.

Prof Clara Chow, University of Sydney

Role of Digital Health in Hypertension Management

Professor Clara Chow is a cardiologist committed to reducing the burden of cardiovascular disease through prevention and innovative approaches to achieve this. She is Program Director Community Based Cardiac Services, Westmead Hospital and Professor of Medicine, Western Clinical School, Sydney Medical School, University of Sydney. She has a PhD in Medicine from the University of Sydney and completed a postdoc in Cardiovascular epidemiology and clinical trials at McMaster University, Canada. Clara holds a Career Development Fellowship of the NHMRC co-funded by the National Heart Foundation. She has over 100 publications, focused on clinical and community approaches to cardiovascular prevention and including papers in leading international journals. She led the initial TEXT ME trial that showed text messaging programs were effective in lowering cholesterol, blood pressure and weight in patients with coronary heart disease.

Prof Stephen Nicholls, Director of Victorian Heart Hospital, Monash Heart & ICU, Monash Health

Lipid Management in High-Risk Populations

Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023. Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations. His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. Professor Nicholls is the 2023 recipient of the Anitschkow Prize from the European Atherosclerosis Society. He is Chair of the Asia Pacific Cardiometabolic Consortium, President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.

Prof Richard O’Brien, University of Melbourne

Diabetes and Hypertension – What’s new?

After completing undergraduate training at the Austin Hospital in Melbourne, Richard O’Brien undertook further studies in diabetic renal disease with Prof. George Jerums, completing a PhD entitled “Diabetic Nephropathy: Early Pathophysiology and Therapeutic Intervention”. He continued his research at the Austin Hospital until 1991 when he moved to Monash Medical Centre. Prof. O’Brien spent 15 years as Head of Diabetes at Monash Medical Centre and moved back to the Austin Hospital in 2007 to take up his current position of Clinical Dean.

Over the last 10 years Prof O’Brien’s research work has focused mainly on aspects of atherosclerosis in diabetes including lipid abnormalities and endothelial dysfunction and he has authored numerous scientific papers on these subjects.

Richard O’Brien is the current President of the Asian Pacific Society of Atherosclerosis and Vascular Diseases and is a past President of the Australian Atherosclerosis Society. He is also currently chair of the Australian Diabetes Society’s Lipid Guidelines Committee, is the convener of the Victorian Lipid Group, and is the Victorian representative on the Australian Atherosclerosis Society Clinical Council.

In addition to his responsibilities in his role as Clinical Dean, Richard O’Brien is strongly committed to post graduate teaching, and has a long-standing interest in continuing education for general practitioners. He is frequently invited to speak at educational and scientific meetings in Australia and overseas. Prof. O’Brien also continues to be involved in direct patient care on a day to day basis and maintains ongoing research interests at the University of Melbourne and Austin Health.

Prof Alta Schutte, University of New South Wales

Update on the National Hypertension Taskforce

Alta (Aletta E.) Schutte PhD, FESC, FRRSAf, ISHF is SHARP Professor and Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine and Health at UNSW Sydney, Australia; with a joint appointment as Professorial Fellow at the George Institute for Global Health. She has extensive experience in working in population-based studies with a focus on raised blood pressure, hypertension and cardiovascular disease.

She has vast experience in working in the field of hypertension and cardiovascular disease within Africa, but also as part of global projects. She has been the Chief Investigator of several multidisciplinary studies (POWIRS, SAfrEIC, African-PREDICT, co-PI of the South African leg of the PURE study), published ~400 papers in the field of blood pressure and cardiovascular disease, and supervised over 85 postgraduate students.

She is Co-lead of the National Hypertension Taskforce launched in December 2022 aimed at improving hypertension control rates in Australia from currently 32% to more than 70% by 2030.

Prof Jonathan Shaw, Baker Heart & Diabetes Institute

Novel approaches to reduce cardiometabolic risk

Professor Jonathan Shaw underwent his clinical and research training in the UK. He is Deputy Director (Clinical and Population Health) at Melbourne’s Baker Heart and Diabetes Institute, where his research focuses on epidemiology and clinical research in diabetes, and he is also a consultant physician in the diabetes services.

He has authored over 500 peer-reviewed scientific papers and 35 book chapters. He is the Chair of the Diabetes Advisory Group to the Australian Institute of Health and Welfare, Council member of the Australian Diabetes Society, and a Past-President of the International Diabetes Epidemiology Group. His awards include the global Novartis Diabetes Award (for research) (2006), the International Diabetes Epidemiology Group Peter Bennett award (2011), the Australian Diabetes Society’s Jeff Flack Diabetes Data award (2015), and the Australian Diabetes Society’s Kellion award (2018).

In 2014, he was included in the Thomson Reuters The World’s Most Influential Scientific Minds, which listed the 1% most highly cited scientists in the world since 2002. In 2017 and 2018, he was included in the Clarivate list of the world’s most Highly Cited Researchers. In 2020, he was listed in the Stanford University listing of the world’s top 2% of researchers.

Prof Markus Schlaich, University of Western Australia

ESH 2023 Guidelines – Implications for Australia

Professor Schlaich is a nephrologist and a European Society of Hypertension (ESH) accredited hypertension specialist with a strong background in clinical research. He is the inaugural Dobney Chair in Clinical Research, Head of the Dobney Hypertension Centre at Royal Perth Hospital/University of Western Australia, and current President of Hypertension Australia. He is Co-Chair of the recently established National Hypertension Taskforce of Australia. He has specific interest in difficult to control hypertension and contributed to the development of novel pharmacologic and device-based treatment approaches for resistant hypertension. He has authored more than 450 articles and book chapters in cardiovascular medicine and serves on the Editorial Board of Hypertension, Journal of Hypertension, and Current Hypertension Reports.

Prof Louise Purton

Women in Hypertension

Professor Louise Purton is internationally recognised for her research delineating the intrinsic and extrinsic regulation of blood cell production in healthy and cancer states. She received the 2022 International Society for Experimental Hematology McCulloch and Till Award for her exceptional research contributions to the field of haematology and stem cells, being the first Australian woman to receive this award.

Louise is also passionate about fostering the career development of the younger researchers and is an advocate for supporting all underrepresented groups in the workplace. In 2021 she founded Equity in Australian STEMM, which is a grassroots organisation comprising academics in Australia. Their advocacy significantly contributed to the recent changes in the NHMRC Investigator Grant funding scheme to improve funding outcomes for women and non-binary applicants. She has also made significant changes to improve the support of underrepresented groups in hematology internationally and received the 2023 International Society for Experimental Hematology Award for Leadership in Diversity, Equity and Inclusivity for her contributions to the field.

Louise has had a profound bilateral hearing impairment since she was a child, and recently became a recipient of two cochlear implants

Dr Saraid Billiards

Women in Hypertension

Dr Saraid Billiards is the CEO of the Association of Australian Medical Research Institutes, the peak body representing medical research institutes across Australia.
Saraid’s career in the health and medical research sector spans more than two decades, with over a decade working in Australia’s largest Government funding agencies – the National Health and Medical Research Council and the Medical Research Future Fund. Previously, Saraid led up Strategy and Engagement for Science in Australia Gender Equity, a transformative program helping Australian academic institutions achieve systemic change for gender equity.
Saraid is a highly regarded leader, policy maker and researcher. She is passionate about health and medical research and advancing gender equality, diversity and inclusion in the sector.
Saraid has a PhD in neurophysiology from Monash University and was a fellow in the Department of Neuropathology, Harvard Medical School.

Learn More About High Blood Pressure (HBP)

Possibly add educative video content

The reasons for developing high blood pressure are complex and can include lifestyle (e.g. diet and physical activity), genetic factors, and other medical conditions.

It is IMPORTANT you follow your doctor’s advice. If you are prescribed a medicine to help treat your high blood pressure, it will not cure it, but it will help control your blood pressure. So it is important to take it every day as advised.

Past Meetings And Reports

Named Lectureships

No. Year Venue R D Wright Lecturer Austin Doyle Lecturer Colin I Johnston Lecturer
Alberto Zanchetti
J. Henry
L. Tobian
John Swales
Garry Nicholls
Peter Sever
A. Cowley
Hans Brunner
S. Schwartz
Tony Lever
Allyn Mark
Stevo Julius
Graham MacGregor M. Schalekamp
Guiseppe Mancia
Wayne Alexander
John Connell
Pierre Corvol
John Shine
Loring Rowell
Stephen MacMahon
Takao Saruta
Wendy Hoy
Suzanne Oparil -Keynote: Martha Hill
Grant Sutherland
David Webb
David Webb
Alan Lopez
Robert Graham
Max Bennett
Melbourne (AHMRC)
Arya Sharma
Arya Sharma
Ernesto Schiffrin Keynote: Ian Wilkinson
Robert Lewis
Sydney (AHMRC)
Yutaka Imai
Peter Doherty
Anna Dominiczak
Terry Dwyer
Shaun Jackson
Freidrich Luft
John Mattick
Mark Febbraio
Guido Grassi Keynote: Lars Lindholm
Ian Frazer
Tien Wong
Carlos Ferrario
David Sinclair
Bruce Neal
Frans Leenen
Michael Cowley
Alex Brown
David Harrison
David Harrison
Anthony Ashton
Peter Rothwell
Rob Parton
Martin Ng
Sydney (Hypertension Sydney)
Eric Olson
Peter Doherty
Chris Sobey
Melbourne (joint with AAS)
William Sessa
Simon McKeon
Markus Schlaich
Adelaide (joint with AAS, AVBS, ASCEPT-CV, ISCP)
Rhian Touyz
Brian Schmidt
Tom Marwick
Melbourne, AMREP
Michael Joyner
Steve Simpson
Gemma Figtree
Hobart (joint with AAS and AVBS)
Nilesh Samani
Alan Cooper
Chris Semsarian
Melbourne, Victoria University
David Ellison
Caroline McMillen
Fadi Charchar
Stamford Hotel, Glenelg, SA
Stephane Laurent
Melissa Little
James Sharman
Brisbane Convention and Exhibition Centre
Alta Schutte
Ingrid Scheffer
Grant Drummond
Martha Gulati
Suzanne Cory
Elisabeth Lambert
Neil Poulter
Clare Collins
Clara Chow
Melbourne Business School
Tazeen Jafar
Laura Mackay
Rebecca Ritchie
Melbourne Business School
Richard McManus
Nikola Bowden
Jun Yang


Interested in joining?


Nominate a colleague for
an award

Awards & Grants

Early Career Researcher (ECR) Oral and Poster Awards

Supported by the High Blood Pressure Research Council of Australia

The candidate must be an early career scientist (up to 10 years post-doctorate, with consideration given for career interruption).

Student Oral and Poster Presentation Awards

Supported by the High Blood Pressure Research Council of Australia

The candidate must be a student currently enrolled in an Honours, Masters or PhD program in a field relevant to the award.

Prizes and Eligibility

All finalists are selected based on the ranking of their abstracts submitted by the normal process for presentation at the Annual Scientific Meeting of the Council. The winner of each prize will be decided by a judging panel based on the quality of the data and the presentation.

In order to be eligible for any of the awards listed above, you MUST:

  • be a member of the HBPRCA in the year of application
  • be the first author of the abstract
  • NOT have published the work presented in the abstract in other than electronic form, at the time of submission.
  • NOT to have won an award in same category previously.

Best Oral Prizes – a certificate will be awarded to the best presentation in the Early Career Researcher Oral Award Finalists Session and also to the best Student Oral Presentation,  in addition to either the AHA or BIHS awards explained below for a total prize of $3,000.
Best Poster Prizes of $500 will be awarded to the best Early Career Researcher presentation and also to the best student presentation.

Supported by the High Blood Pressure Research Council of Australia and the British and Irish Hypertension Society (BIHS)

This is a single award to the highest scoring presentation from either the Early Career Investigator Oral Award Finalists or the Student Oral Presentation Award Finalists. It underlines the society’s strong alliance with the BIHS. The prize is a formal invitation to attend and present at the following BIHS Annual Scientific meeting in September. The award comprises an amount of $3,000 towards travel expenses. Accommodation and registration will be provided by the BIHS during the meeting in the UK. The recipient is also expected to visit laboratories with like research interests before or after the meeting (it is compulsory to visit at least one laboratory). The winner is not eligible for this award in subsequent years.

Supported by the High Blood Pressure Research Council of Australia and the American Heart Association Council on Hypertension.

This is a single award to the highest scoring presentation from either the Early Career Investigator Oral Award Finalists or the Student Oral Presentation Award Finalists. It underlines the society’s strong alliance with the American Heart Association. The prize is a formal invitation to attend and present at the following AHA Hypertension Scientific Sessions, typically held in September. The award comprises an amount of $3,000 towards travel expenses. Accommodation and registration will be provided by the American Heart Association’s Council on Hypertension during the meeting in the US. The recipient is also expected to visit laboratories with like research interests before or after the meeting. The winner is not eligible for this award in subsequent years.

*If you won the poster or oral prize last year you are not eligible for the poster or oral prize in this year in the same category. A student winner who becomes a full member of the Council is eligible for the ECR award the following year.

Travel grants-in-aid are offered to student members of the HBPRCA to encourage participation in the HBPRCA Annual Scientific Meeting (ASM). Applicants must be a student member of the HBPRCA by September 30 in the year of application, a full-time student in Australia or New Zealand and presenting at the meeting. If a travel grant is approved, available funds will be distributed following attendance to the meeting in the amount approved by the Executive Committee. Applicants must indicate on the Presenting Author Form when submitting their abstract if they would like to be considered for a travel grant. Applicants will be notified at the time of program announcement.

The Robert Vandongen Travel Award is presented to the researcher from WA whose abstract scores most highly at the ASM. No application is required.

How To Apply

The candidate must submit an abstract for the annual High Blood Pressure Research Council of Australia meeting online via the official conference website. Please e-mail admin@hypertension.org.au for more details.
When submitting the abstract the candidate must check the box to be considered for an award. Boxes for both oral and poster prizes may be checked but the candidate will only be considered as a finalist in one category. Travel awards are considered separately.

Robert Vandongen award:
2016: Denise Demmer
2018: Jacquinta Affandi
2019: Revathy Carnagarin
2020: Ashish Yadav
2021: Lakshini Heart
2022: Markus Schlaich

Prof Judith Whitworth was the first woman to be elected as the president of the HBPRCA (1999-2001). Throughout her career, Prof Whitworth not only contributed to a major way to high blood pressure research herself, and in particular to the mechanisms involved in steroid-related hypertension, but broke numerous barriers and paved a path for women in research, clinical practice and policy making.

The highest ranked abstract for which the first named author is a woman will receive the Judith Whitworth Women in High Blood Pressure Research Award. Only current HBPRCA members are eligible.

The awardee will be announced at the ASM, where this person will receive a certificate.

Judith Whitworth award:
2018: Hamdi Jama
2019: Jordyn Thomas
2020: Quynh Nhu Dinh
2021: Buddhila Wickramasinghe
2022: Bhavisha Bakrania

Prof Jaye Chin-Dusting was the second woman to be elected as the president of the HBPRCA (2011-2016). As a founder of the Australian Cardiovascular Alliance, Prof Chin-Dusting was deeply concerned with the funding available for cardiovascular disease, which affects particularly those in the early- and mid-stages of their career. During her presidency of the HBPRCA, she also established the young investigator subcommittee of the HBPRCA, to improve training, networking, and opportunities for early and mid-career high blood pressure researchers.

The highest ranked abstract for which the first author is a mid-career scientist (between 5-20 years post-PhD) will receive the Jaye Chin-Dusting Mid-career Scientist in High Blood Pressure Research Award. Only current HBPRCA members are eligible.

The awardee will be announced at the ASM, where this person will receive a certificate.

Jaye Chin-Dusting award:
2018: Bradley Broughton
2019: Sheila Patel
2020: Francine Marques
2021: James Sharman
2022: Antony Vinh

The Foundation for High Blood Pressure Research is pleased to announce that applications are open for:

Early Career Research Transition Grants 2023-2024

These new grants of up to $20,000 each are intended for early career researchers who need help in reestablishing their research as a result of change in physical location, direction of research or a major career interruption. Unless exceptional, disruptions due to the COVID pandemic will not be considered as sole justification for funding.

The Closing Date for application is Tuesday 8th of November 2022. Please read the Information for Applicants and the Application Form for further details.

Download the Information for Applicants

Download the Application Form

Prof Paul Korner was one of the founders and a former president of the HBPRCA (1987-1989). He devoted a large part of his career to researching the causes of essential hypertension, with a special focus on underlying neural and cardiovascular mechanisms.

A senior scientist (>20 years post-PhD) who is an active researcher and has made a significant contribution to high blood pressure and the HBPRCA will receive the Paul Korner Senior Scientist in High Blood Pressure Research Medal. Only current HBPRCA members who are attending the ASM are eligible (attendance may be excused under certain circumstances).

A one-page nomination by a HBPRCA member must be received by 31 October of each year outlining the contributions to high blood pressure research and the HBPRCA, and to mentoring of basic or clinical researchers in high blood pressure. Self-nominations will not be accepted. A sub-committee of 3-5 members of the HBPRCA executive committee will select the most suitable nominee each year.

The awardee will be announced at the ASM and the winner will receive an engraved medal.

Paul Korner medal:
2018: Stephen Harrap
2019: Louise Burrell
2020: Murray Esler
2021: Geoffrey Head
2022: Lawrie Beilin